Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident-With focus on immunoglobulin heavy chain gene analysis

Leukemia Research

Volumn 32, Issue 4, 2008, Pages 535-545

  Abramenko, Iryna ^a   Bilous, Nadia ^a   Chumak, Anatoliy ^a   Davidova, Ekaterina ^b   Kryachok, Iryna ^a   Martina, Zoya ^a   Nechaev, Stanislav ^a   Dyagil, Iryna ^a   Bazyka, Dmytriy ^a   Bebeshko, Vladimir ^a  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^b All Russian Center on Quality and Standardization of Veterinary Medications and Feed   (Russian Federation)

Author keywords

Chronic lymphocytic leukemia; Immunoglobulin variable heavy chain (IgVH) gene usage; Ionizing radiation

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; CHERNOBYL ACCIDENT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; IONIZING RADIATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RADIATION EXPOSURE; SOLID TUMOR;

ADULT; AGED; CHERNOBYL NUCLEAR ACCIDENT; COHORT STUDIES; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; POLYMERASE CHAIN REACTION; RADIATION, IONIZING; SURVIVAL RATE;

EID: 39049132804     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.08.013     Document Type: Article

References (36)

1. Caligaris-Cappio F., Scielzo C., Camporeale A., and Ghia P. Biology of chronic lymphocytic leukemia: new perspectives. Hematology 1 (2005) 192-195
2. Stilgenbauer S., Lichter P., and Dohner H. Genetic features of B-cell chronic lymphocytic leukemia. Rev Clin Exp Hematol 4 (2000) 48-72
3. Tobin G., Thunberg U., Karlsson K., Murray F., Laurell A., Willander K., et al. Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 104 (2004) 2879-2885
4. Chiorazzi N., Rai K.R., and Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 352 (2005) 804-815
5. Court-Brown W., and Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J 2 (1965) 1327-1332
6. Finch S.C., Hoshito T., Itoga T., Ichimaru M., and Ingram Jr. R.H. Chronic lymphocytic leukemia in Hiroshima and Nagasaki, Japan. Blood 33 (1969) 79-86
7. Darby S.C., Doll R., Gill S.K., and Smith P.G. Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 55 (1987) 179-190
8. Preston D.L., Kusumi S., Tomonaga M., Izumi S., Ron E., and Kuramoto A. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 137 (1994) 68-97
9. Weiss H.A., Darby S.C., and Doll R. Cancer mortality following X-rays treatment for ankylosing spondylitis. Int J Cancer 59 (1994) 327-338
10. Inskip P.D., Kleinerman R.A., Stovall M., Cookfair D.L., Hajimichael O., and Moloney W.C. Leukemia, lymphoma, and multiple myeloma after pelvix radiotherapy for benign disease. Radiat Res 135 (1993) 108-124
11. Bazyka D., Romanenko A., and Bebeshko V. Leukemia in Ukrainian clean-up workers of the Chornobyl accident: epidemiologic and hematologic aspects. Haematologica 91 (2006) 68
12. Hatch M. Cancer following the Chornobyl nuclear accident (the Ukrainian-American Studies of thyroid disease and leukemia). J Acad Med Sci Ukraine 12 (2006) 78-85
13. Klymenko V., Kryachok I., Dyagil I., Bazyka D., and Bebeshko V. Some clinical and hematologic features of CLL in persons who suffered from the Chernobyl accident in Ukraine in 1986. VIII International Workshop on CLL. Paris, October 29-31 (1999) [Abstract Book 1999:43]
14. Kryachok I., Polyshchuk O., Dyagil I., Abramenko I., Bazyka D., and Bebeshko V. Comparative analysis of CLL in persons who suffered after Chernobyl accident and in unexposed CLL patients. 10th Congress of the European Hematology Association. Haematologica 90 (2005) 454
15. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., and Pasternack B.S. Clinical staging of chronic lymphocytic leukemia. Blood 46 (1975) 219-234
16. Rai K.R. A critical analysis of staging in CLL. In: Gale R.P., and Rai K.R. (Eds). Chronic lymphocytic leukemia (1987), Alan R. Liss, Inc., NY 253-264
17. Binet J.L., Auguier A., Dighiero G., Chastang C., Piquet H., Coasguen J., et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48 (1981) 198-206
18. International Workshop on Chronic Lymphocytic Leukemia. Chronic lymphocytic leukemia: recommendations for diagnosis, staging, and response criteria. Ann Intern Med 110 (1989) 236-238
19. Repin V.S. Dose reconstruction and assessment of the role some factors in radiation exposure to inhabitants, evacuated outside the 30-km zone after the Chernobyl accident. In: Grodzinsky D. (Ed). Problems of Chernobyl zone (1996), Naukova Dumka, Kyiv 451
20. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
21. van Dongen J.J., Langerak A.W., Bruggemann M., Evans P.A., Hummel M., Lavender F.L., et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17 (2003) 2257-2317
22. Lefranc M.P. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 29 (2001) 207-219
23. Souto-Carneiro M.M., Longo N.S., Russ D.E., Sun H.-W., and Lipsky P.E. Characterization of the human Ig heavy chain antigen binding complementary determining region 3 using a newly developed software algorithm, JOINSOLVER. J Immunol 172 (2004) 6790-6802
24. Widhopf G.F., Rassenti II L.Z., Toy T.L., Gribben J.G., Wierda W.G., and Kipps Th.J. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 104 (2004) 2499-2504
25. Messmer B.T., Albesiano E., Efremov D.G., Gjiotto F., Allen S.L., Kolitz J., et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 200 (2004) 519-525
26. Stamatopoulos K., Belessi C., Moreno C., Boudiograh M., Guida G., Smilevska T., et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood 109 (2007) 259-270
27. Cheson B.D., Bennett J.M., and Grever M. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87 (1996) 4990-4997
28. Hamblin T.J., Davis Z., Garddiner A., Oscier D.G., and Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukaemia. Blood 94 (1999) 1848-1854
29. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94 (1999) 1840-1847
30. Ghia P., Stamatopoulos K., Belessi Ch, Moreno C., Stella S., Guida G., et al. Geographic patterns and pathogenetic implications of IGVH gene usage in chronic lymphocytic leukemia: the lesson of the IGVH3-21 gene. Blood 105 (2005) 1678-1685
31. Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S.L., et al. Chronic lymphocytic leukemia B cells express restricted set of mutated and unmutated antigen receptors. J Clin Invest 102 (1998) 1515-1525
32. World Health Organization. Health consequences of the Chernobyl accident. Results of the IPHECA pilot projects and related national programmes. Scientific report. Moscow: Vidar Ltd.; 1996. 518 pp.
33. Pritsch O., Magnac C., Dumas G., Egile C., and Dighiero G. V gene usage by seven hybrids derived from CD5+ B-cell chronic lymphocytic leukemia and displaying autoantibody activity. Blood 82 (1993) 3103-3112
34. Weitkamp J.H., LaFleur B.J., and Crowe Jr. J.E. Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody repertoire compared with CD5- B cells. Hum Immunol 67 (2006) 33-42
35. Kramer R.A., Marissen W.E., Goudsmit J., Visser T.J., Clijsters-Van der Horst M., Bakker A.Q., et al. The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries. Eur J Immunol 35 (2005) 2131-2145
36. Oscier D.G., Thompsett A., Zhu D., and Stevenson F.K. Differential rates of somatic hypermutation in VH genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood 89 (1997) 4153-4160